Hannah brings over 8 years of experience in the healthcare industry, driving strategic projects across diverse therapeutic areas including cardiovascular, immunology, and rare disease. She specializes in late lifecycle management, with a particular focus on biosimilars, helping clients navigate complex market dynamics and optimize commercial strategies.​

​Prior to joining Align Strategy, Hannah was a member of the analyst and consulting team at Datamonitor Healthcare (part of Informa Pharma Intelligence), where she gained valuable experience conducting in-depth analyses of therapeutic assets, competitive market landscapes, financial modelling, and opportunity assessments. ​

Hannah holds a BSc with Honours in Neuroscience from the University of Nottingham.

Outside of work, Hannah enjoys yoga, long walks with her beautiful dog, and exploring new places around the world.